American Society of Clinical Oncology® – Gastrointestinal Cancers Symposium
San Francisco, CA
Jan 08 - Jan 10
Poster Presentation
Real-world clinical outcomes among metastatic colorectal cancer (mCRC) patients with liver metastases who received trifluridine/tipiracil (FTD/TPI) monotherapy or FTD/TPI + bevacizumab (FTD/TPI+bev) combination therapy
By downloading this material, you acknowledge that this action may be considered a transfer of value and will be reported by Taiho Oncology, Inc. in accordance with applicable Transparency and Sunshine Act requirements.